. . . . . . . . "No change in sumoylation levels. Loss of protein stability. Reduced MOS/MAPK-mediated transforming ability; when associated with A-362." . "260"^^ . . "260"^^ . . . . . . "Increased protein stability. Increased MOS/MAPK-mediated transforming ability and no change in sumoylation levels; when associated with D-362." . "260"^^ . . "260"^^ . . "Mutagenesis site occurs in NX_P01100-2 at amino acids 260 - 260." . . . . . . "neXtProt gold" . . . . . . . . . . . . . "2014-09-19T00:00:00.0Z"^^ . . . "neXtProt database" . "CALIPHO project" . . . . . "1" . . . . .